SEM: Select Medical (SEM) filed the preliminary proxy statement for its acquisition by a Co-Founder-led consortium. The company expects the merger to be completed in the middle of 2026.
KVUE: Kimberly‑Clark (KMB) announced the organizational structure and key leadership that will become effective upon completion of its acquisition of Kenvue (KVUE). The deal remains on track to close in the second half of 2026.
LSTA: Lisata Therapeutics (LSTA) announced that Kuva Labs has not yet commenced the tender offer. Lisata has been informed by Kuva that it is currently seeking alternative sources of financing on terms more favorable to fund the tender offer, and intends to launch the tender offer when its financing is finalized.
Only plus or premium subscribers can access this post.
Subscribe today.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
